CYP26B1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CYP26B1 monoclonal antibodies for research focused on understanding this important enzyme. CYP26B1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP26B1 is a member of the cytochrome P450 family and plays a crucial role in the metabolism of retinoic acid, which is essential for proper embryonic development and cellular differentiation. Dysregulation of CYP26B1 has been implicated in various developmental disorders and diseases, making it a significant target for research. Understanding CYP26B1 function can provide insights into retinoic acid signaling pathways and their impact on health and disease. Researchers can explore the relationship between CYP26B1 and cellular development through detailed molecular analysis. Advanced imaging techniques combined with specific molecular markers allow for precise tracking of CYP26B1 activity in various biological systems. The role of CYP26B1 in development continues to reveal new aspects of cellular regulation and differentiation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CYP26B1's role in human health and disease.